An interventional study of Training in water and Training on land in Chronic Obstructive Pulmonary Disease, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 50 Years to 75 Years. Per ClinicalTrials.gov, last updated 2022-03-07.
Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Prevention
The purpose of this study is to determine whether water based or land based group training is more effective for people with COPD.
COPD is a more common diagnosis today compared to 20 years ago, and the group is growing fast. The suffering caused by COPD and the financial cost to society is on the increasing. The principal causes of COPD are smoking and inactivity. So far it is poorly understood wich form of exercise is the most effective in training this condition.
3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.
This study's enrollment of 22 is below the median of 72 across 2,118 interventional studies indexed under Lung Diseases.
Browse Lung Diseases studies →Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
B1 - training in water
Behavioral: Training in water
S1 - training on land
Behavioral: Training on land
45 minutes interval training in water, submaximal intensity, twice a week
45 minutes interval training on land, submaximal intensity, twice a week
VO2 peak
Time frame: 12 weeks
Health related quality of life
Time frame: 12 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Norwegian University of Science and Technology